Assembly Biosciences ASMB Operating margin

Operating margin at other companies

Arrowhead ResearchARWR

-35.7%+63.6pp

ALN

Alnylam PharmaceuticalsALNY

20.8%+16.5pp

Avalo TherapeuticsAVTX

-15,536.1%-17,275pp

Arbutus Biopharma CorporationABUS

81.7%+42.1pp

Vir Biotechnology, Inc.VIR

-92.4%-45.5pp

Absci CorporationABSI

-8,084.5%-17,708pp

FAQ

What is Assembly Biosciences's operating margin?

Assembly Biosciences (ASMB) reported operating margin of -116.8% in Q3 2025.

How has Assembly Biosciences's operating margin changed year-over-year?

Assembly Biosciences's operating margin increased by 28.7% year-over-year, from -163.9% to -116.8%.

What is the long-term trend for Assembly Biosciences's operating margin?

Over 2 years (2020 to 2024), Assembly Biosciences's operating margin has grown at a 39.5% compound annual growth rate (CAGR), from -81.9% to -159.3%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.